Characteristics of sars-coV-2 and covid-19

80, 373–377 (2020).
6
. 
Zhu, N. et al. A Novel Coronavirus from patients with 
pneumonia in China, 2019. N. Engl. J. Med. 382, 
727–733 (2020).
7
. 
Gralinski, L. E. & Menachery, V. D. Return of the 
coronavirus: 2019-nCoV. Viruses 12, 135 (2020).
8
. 
Jiang, S., Du, L. & Shi, Z. An emerging coronavirus 
causing pneumonia outbreak in Wuhan, China: calling 
for developing therapeutic and prophylactic strategies. 
Emerg. Microbes Infect.
9, 275–277 (2020).
9
. 
Wu, Z. & McGoogan, J. M. Characteristics of and 
important lessons from the coronavirus disease 2019 
(COVID-19) outbreak in china: summary of a report
of 72314 cases from the Chinese Center for Disease 
Control and Prevention. JAMA 323, 1239–1242 
(2020).
10
. Wu, F. et al. A new coronavirus associated with human 
respiratory disease in China. Nature 579, 265–269 
(2020).
11
. Zhou, P. et al. A pneumonia outbreak associated with 
a new coronavirus of probable bat origin. Nature 579, 
270–273 (2020).
12
. Chan, J. F. et al. A familial cluster of pneumonia 
associated with the 2019 novel coronavirus indicating 
person- to-person transmission: a study of a family 
cluster. Lancet 395, 514–523 (2020).
13
. Chen, N. et al. Epidemiological and clinical 
characteristics of 99 cases of 2019 novel coronavirus 
pneumonia in Wuhan, China: a descriptive study. 
Lancet
395, 507–513 (2020).
14
. Wang, R., Zhang, X., Irwin, D. M. & Shen, Y. 
Emergence of SARS- like coronavirus poses new 
challenge in China. J. Infect. 80, 350–371 (2020).
15
. National Health Commission of the People’s
Republic of China. Briefing on the latest situation
of the novel coronavirus pneumonia epidemic.
http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml
(2020).
16
. Eurosurveillance Editorial Team. Note from the editors: 
World Health Organization declares novel coronavirus 
(2019-nCoV) sixth public health emergency of 
international concern. Euro. Surveill. 25, 200131e 
(2020).
17
. Coronaviridae Study Group of the International 
Committee on Taxonomy of Viruses. The species 
severe acute respiratory syndrome- related 
coronavirus: classifying 2019-nCoV and naming it 
SARS- CoV-2. Nat. Microbiol. 5, 536–544 (2020).
18
. Fisher, D. & Heymann, D. Q&A: the novel coronavirus 
outbreak causing COVID-19. BMC Med. 18, 57 
(2020).
19
. Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J.
& Hsueh, P. R. Severe acute respiratory syndrome 
coronavirus 2 (SARS- CoV-2) and coronavirus 
disease-2019 (COVID-19): the epidemic and the 
challenges. Int. J. Antimicrob. Agents 55, 105924 
(2020).
20
. World Health Organization. Coronavirus disease
2019 (COVID-19). Situation report – 51. 
https:// 
www.who.int/docs/default- source/coronaviruse/
situation- reports/20200311-sitrep-51-covid-19.
pdf?sfvrsn=1ba62e57_10
 (2020).
21
. Dong, E., Du, H. & Gardner, L. An interactive web- based 
dashboard to track COVID-19 in real time. Lancet Infect. 
Dis.
20, 533–534 (2020).
22
. Li, Q. et al. Early transmission dynamics in Wuhan, 
China, of novel coronavirus- infected pneumonia.
N. Engl. J. Med.
382, 1199–1207 (2020).
23
. Deslandes, A. et al. SARS- CoV-2 was already spreading 
in France in late December 2019. Int. J. Antimicrob. 
Agents
55, 106006 (2020).
24
. Lu, R. et al. Genomic characterisation and epidemiology 
of 2019 novel coronavirus: implications for virus origins 
and receptor binding. Lancet 395, 565–574 (2020).
25
. Chan, J. F. et al. Genomic characterization of the 2019 
novel human- pathogenic coronavirus isolated from a 
patient with atypical pneumonia after visiting Wuhan. 
Emerg. Microbes Infect.
9, 221–236 (2020).
26
. Anderson, K. G., Rambaut, A., Lipkin, W. I.,
Holmes, E. C. & Garry, R. F. The proximal origin
of SARS- CoV-2. Nat. Med. 26, 450–452 (2020).
27
. Coutard, B. et al. The spike glycoprotein of the new 
coronavirus 2019-nCoV contains a furin- like cleavage 
site absent in CoV of the same clade. Antiviral Res. 
176, 104742 (2020).
28
. Zhou, H. et al. A novel bat coronavirus closely related 
to SARS- CoV-2 contains natural insertions at the S1/S2 
cleavage site of the spike protein. Curr. Biol. 30, 
2196–2203 (2020).
29
. Wrobel, A. G. et al. SARS- CoV-2 and bat RaTG13 spike 
glycoprotein structures inform on virus evolution and 
furin- cleavage effects. Nat. Struct. Mol. Biol. 27,
763–767 (2020).
30
. Su, Y. C. F. et al. Discovery and genomic characterization 
of a 382-nucleotide deletion in ORF7b and ORF8 
during the early evolution of SARS- CoV-2. mBio 11, 
e01610-20 (2020).
31
. Zhao, W. M. et al. The 2019 novel coronavirus resource. 
Yi Chuan
42, 212–221 (2020).
32
. Korber, B. et al. Tracking changes in SARS- CoV-2 
spike: evidence that D614G increases infectivity of the 
COVID-19 virus. Cell 182, 812–827 (2020).
33
. Tang, X. et al. On the origin and continuing evolution 
of SARS- CoV-2. Natl Sci. Rev. 7, 1012–1023 (2020).
34
. Forster, P., Forster, L., Renfrew, C. & Forster, M. 
Phylogenetic network analysis of SARS- CoV-2 genomes. 
Proc. Natl Acad. Sci. USA
117, 9241–9243 (2020).
35
. Paraskevis, D. et al. Full- genome evolutionary analysis 
of the novel corona virus (2019-nCoV) rejects the 
hypothesis of emergence as a result of a recent 
recombination event. Infect. Genet. Evol. 79, 104212 
(2020).
36
. Hu, D. et al. Genomic characterization and infectivity 
of a novel SARS- like coronavirus in Chinese bats. 
Emerg. Microbes Infect.